Year in Review 2024 - Hepatobiliary Cancers

Oncology 2024 Year in Review

R. Kim, T. Biachi

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Cancer Screening Molecular Tools

Fengting Yan

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Integrity CE

V. Lee, R. Kumar, N. Bhagat, E. Winslow

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Integrity CE

V. Lee, E. Christenson, N. Bhagat, E. Winslow

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Integrity CE

J. Birkness-Gartman

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Total Health

A. Grothey

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

SoC and Future Perspectives in Biliary Tract Cancer

Arndt Vogel

GI Oncology Year in Review: Hepatobiliary Cancers

Yale Cancer Center

P. Kunz

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"

2024 ASCO® Annual Meeting Insights Hub

A. Vogel

Precision Medicine in GI Cancers

Fred Hutchinson Cancer Center

D. Zhen

The Importance of Proactive Management of AEs Associated with FGFR2i…

Angelo Pirozzi

Updates in Targeted Therapies for Metastatic Biliary Tract Cancers

Integrity CE

J. Harding

ESMO 2024 Summary: IDH Mutated Cholangiocarcinoma - Diagnostic and T…

2024 ESMO Annual Meeting Insights Hub

T. Macarulla Mercade

ESMO GI 2024 Insights: Durvalumab + Chemo in Biliary Tract Cancer - …

Insights from 2024 ESMO GI Annual Meeting

D. Oh